Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study
Eli Muchtar(Mayo Clinic), Hila Magen(Sheba Medical Center), Evgeni Chubar(Emek Medical Center), Ory Rouvio(Soroka Medical Center), Tamar Tadmor(Bnai Zion Medical Center), Tzippy Shochat(Rabin Medical Center), Chezi Ganzel(Shaare Zedek Medical Center), Yaël C. Cohen(Sheba Medical Center), Irit Avivi(Tel Aviv Sourasky Medical Center), Olga Shevetz, Pia Raanani(Tel Aviv University), Moshe E. Gatt(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Celia Suriu(Western Galilee Hospital), Noa Lavi(Rambam Health Care Campus)
Cited by 38
Related Papers
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
|Blood|2017|344
Systemic amyloidosis from A (AA) to T (ATTR): a review
|Journal of Internal Medicine|2020|329
Restrictive Cardiomyopathy
|Circulation Research|2017|320